XTRA:IVX

Stock Analysis Report

Executive Summary

InVision Aktiengesellschaft develops and markets products and services in the field of workforce management and education in Europe and the United States.

Snowflake

Fundamentals

Excellent balance sheet with concerning outlook.

Share Price & News

How has InVision's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

0%

IVX

0.3%

DE Software

1.4%

DE Market


1 Year Return

15.9%

IVX

19.5%

DE Software

3.7%

DE Market

Return vs Industry: IVX underperformed the German Software industry which returned 19.5% over the past year.

Return vs Market: IVX exceeded the German Market which returned 3.7% over the past year.


Shareholder returns

IVXIndustryMarket
7 Day0%0.3%1.4%
30 Day4.4%6.3%1.8%
90 Day13.8%2.8%3.4%
1 Year15.9%15.9%21.1%19.5%7.0%3.7%
3 Year-51.2%-52.0%49.4%43.4%18.5%8.3%
5 Year-53.2%-57.3%147.1%129.5%42.2%22.9%

Price Volatility Vs. Market

How volatile is InVision's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is InVision undervalued compared to its fair value and its price relative to the market?

4.88x

Price to Book (PB) ratio


Share Price vs. Fair Value

Undervalued: IVX (€19) is trading above our estimate of fair value (€0.86)

Significantly Undervalued: IVX is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: IVX is unprofitable, so we can't compare its PE Ratio to the Software industry average.

PE vs Market: IVX is unprofitable, so we can't compare its PE Ratio to the German market.


Price to Earnings Growth Ratio

Low PEG Ratio: Insufficient data to calculate IVX's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: IVX is overvalued based on its PB Ratio (4.9x) compared to the DE Software industry average (3x).


Next Steps

Future Growth

How is InVision forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?

68.1%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: IVX is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: IVX is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: IVX is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: IVX's revenue (5.5% per year) is forecast to grow faster than the German market (5% per year).

High Growth Revenue: IVX's revenue (5.5% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

High Future ROE: IVX's Return on Equity is forecast to be low in 3 years time (6.9%).


Next Steps

Past Performance

How has InVision performed over the past 5 years?

-46.9%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Earnings Trend: IVX is unprofitable, and losses have increased over the past 5 years at a rate of -46.9% per year.

Accelerating Growth: Unable to compare IVX's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: IVX is unprofitable, making it difficult to compare its past year earnings growth to the Software industry (14.5%).


Return on Equity

High ROE: IVX has a negative Return on Equity (-0.14%), as it is currently unprofitable.


Return on Assets

ROA vs Industry: IVX is currently unprofitable, so its Return on Assets is negative.


Return on Capital Employed

ROCE Improving: IVX is currently unprofitable, so its Return on Capital Employed is negative.


Next Steps

Financial Health

How is InVision's financial position?


Financial Position Analysis

Short Term Liabilities: IVX's short term assets (€5.4M) exceeds its short term liabilities (€3.7M)

Long Term Liabilities: IVX's short term assets (5.4M) exceeds its long term liabilities (2.4M)


Debt to Equity History and Analysis

Debt Level: IVX's debt to equity ratio (1.7%) is considered satisfactory

Reducing Debt: IVX's debt to equity ratio has reduced from 66% to 1.7% over the past 5 years.

Debt Coverage: IVX's debt is well covered by operating cash flow (699%).

Interest Coverage: IVX is unprofitable, therefore interest payments are not well covered by earnings.


Balance Sheet

Inventory Level: IVX has a high level of physical assets or inventory.

Debt Coverage by Assets: IVX's debt is covered by short term assets (assets are 30.704900x debt).


Next Steps

Dividend

What is InVision's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

company0%marketbottom25%1.5%markettop25%3.8%industryaverage1.3%forecastin3Years0%

Current dividend yield vs market & industry


Stability and Growth of Payments

Notable Dividend: Unable to evaluate IVX's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate IVX's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.

Stable Dividend: Insufficient data to determine if IVX's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if IVX's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: IVX is not paying a notable dividend for the German market.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of IVX's dividend in 3 years as they are not forecast to pay a notable one for the German market.


Next Steps

Management

What is the CEO of InVision's salary, the management and board of directors tenure and is there insider trading?

€364k

CEO Compensation


CEO

Peter Bollenbeck (46yo)

0yrs

Tenure

€364,015

Compensation

Mr. Peter Bollenbeck co-founded InVision AG in 1995 and serves as its Chairman of the Executive Board and Chief Executive Officer. Mr. Bollenbeck is responsible for strategy, sales, professional services a ...


CEO Compensation Analysis

Compensation vs. Market: Peter's total compensation ($USD405.50K) is above average for companies of similar size in the German market ($USD216.74K).

Compensation vs Earnings: Peter's compensation has increased whilst the company is unprofitable.


Insider Trading

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown


Management Team

  • Peter Bollenbeck (46yo)

    Chairman of Executive Board & CEO

    • Tenure: 0yrs
    • Compensation: €364.02k
  • Armand Zohari (52yo)

    Co-Founder & Member of Executive Board

    • Tenure: 0yrs
    • Compensation: €66.09k

Board Members

  • Matthias Schroer (52yo)

    Deputy Chairman of the Supervisory Board

    • Tenure: 6.2yrs
    • Compensation: €18.75k
  • Thomas Hermes

    Chairman of the Supervisory Board

    • Tenure: 0yrs
    • Compensation: €25.00k
  • Wilhelm Mülder

    Member of the Supervisory Board

    • Tenure: 0yrs
    • Compensation: €12.50k

Company Information

InVision Aktiengesellschaft's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: InVision Aktiengesellschaft
  • Ticker: IVX
  • Exchange: XTRA
  • Founded: 1995
  • Industry: Application Software
  • Sector: Software
  • Market Cap: €42.465m
  • Shares outstanding: 2.24m
  • Website: https://www.ivx.com

Number of Employees


Location

  • InVision Aktiengesellschaft
  • Speditionstraße 5
  • Düsseldorf
  • North Rhine-Westphalia
  • 40221
  • Germany

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
IVXDB (Deutsche Boerse AG)YesOrdinary SharesDEEURJun 2007
IVXXTRA (XETRA Trading Platform)YesOrdinary SharesDEEURJun 2007
0EWOLSE (London Stock Exchange)YesOrdinary SharesGBEURJun 2007
IVXdBATS-CHIXE (BATS 'Chi-X Europe')YesOrdinary SharesGBEURJun 2007

Biography

InVision Aktiengesellschaft develops and markets products and services in the field of workforce management and education in Europe and the United States. Its products include injixo, a workforce managemen ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/10/18 21:11
End of Day Share Price2019/10/18 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.